0001415889-20-000717.txt : 20200310 0001415889-20-000717.hdr.sgml : 20200310 20200310213243 ACCESSION NUMBER: 0001415889-20-000717 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200306 FILED AS OF DATE: 20200310 DATE AS OF CHANGE: 20200310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAMPROPOULOS FRED P CENTRAL INDEX KEY: 0000901534 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18592 FILM NUMBER: 20703767 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIT MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000856982 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870447695 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1600 WEST MERIT PARK WAY CITY: SOUTH JORDAN STATE: UT ZIP: 84095 BUSINESS PHONE: 8012531600 MAIL ADDRESS: STREET 1: 1600 WEST MERIT PARKWAY CITY: SOUTH JORDAN STATE: UT ZIP: 84095 4 1 form4-03102020_060329.xml X0306 4 2020-03-06 0000856982 MERIT MEDICAL SYSTEMS INC MMSI 0000901534 LAMPROPOULOS FRED P 1600 WEST MERIT PARKWAY SOUTH JORDAN UT 84095 true true false false PRESIDENT AND CEO Common Stock, No Par Value 2020-03-06 4 M 0 50000 12.06 A 979991 D Common Stock, No Par Value 2020-03-06 4 M 0 50000 17.27 A 1029991 D Common Stock, No Par Value 2020-03-06 4 F 0 62075 37.58 D 967916 D Common Stock, No Par Value 95384 I By 401(k) Plan Common Stock, No Par Value 1269 I By spouse Common Stock, No Par Value 90 I By spouse as custodian for child Non-qualified stock options (right to buy) 12.06 2020-03-06 4 M 0 50000 0 D 2015-10-04 2021-10-04 Common Stock 50000 0 D Non-qualified stock options (right to buy) 17.27 2020-03-06 4 M 0 50000 0 D 2016-02-13 2022-02-13 Common Stock 50000 0 D Non-qualified stock options (right to buy) 17.27 2016-02-13 2022-02-13 Common Stock 5000 5000 I Please refer to footnote number four. Non-qualified stock options (right to buy) 16.05 2017-01-28 2023-01-28 Common Stock 50000 50000 D Non-qualified stock options (right to buy) 16.05 2017-01-28 2023-01-28 Common Stock 7500 7500 I Please refer to footnote number four. Non-qualified stock options (right to buy) 28.20 2018-04-14 2024-04-14 Common Stock 200000 200000 D Non-qualified stock options (right to buy) 28.20 2018-04-14 2024-04-14 Common Stock 10000 10000 I Please refer to footnote number four. Non-qualified stock options (right to buy) 44.80 2019-03-02 2025-03-02 Common Stock 38002 38002 D Non-qualified stock options (right to buy) 44.80 2019-03-02 2025-03-02 Common Stock 10000 10000 I Please refer to footnote number four. Non-qualified stock options (right to buy) 55.73 2020-03-01 2026-03-01 Common Stock 159151 159151 D Non-qualified stock options (right to buy) 55.73 2020-03-01 2026-03-01 Common Stock 10000 10000 I Please refer to footnote number four. Non-qualified stock options (right to buy) 37.71 2021-02-26 2027-02-26 Common Stock 100334 100334 D Performance Stock Units 2021-03-15 2023-03-15 Common Stock 21215 21215 D Stock options were exercised in a swap transaction with the Company. 62,075 shares of common stock were surrendered for payroll taxes and payment of the option price. No shares were sold in the open market. Represents plan holdings as of 3/09/2020. Becomes exercisable in equal annual installments of 20% commencing 10/4/2015. Becomes exercisable in equal annual installments of 20% commencing 2/13/2016. Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Becomes exercisable in equal annual installments of 20% commencing 1/28/2017. Becomes exercisable in equal annual installments of 20% commencing 4/14/2018. Becomes exercisable in equal annual installments of 20% commencing 3/2/2019. Becomes exercisable in equal annual installments of 20% commencing 3/1/2020 Becomes exercisable in equal annual installments of 25% commencing 2/26/2021. Each performance share unit represents the Company's commitment to issue one share of Merit Medical Systems, Inc. common stock, subject to achievement of performance criteria. If earned by the Reporting Person, the PSUs will be awarded not later than March 15 of the year following the Issuer's achievement of the target level of free cash flow, subject to conditions set forth in the Performance Stock Unit Award Agreement. On February 26, 2020, the reporting person was awarded a target number of performance share units ("PSUs") pursuant to a Performance Stock Unit Award Agreement by and between the Reporting Person and the Issuer. The actual number of PSUs to be awarded to the Reporting Person will be based upon the Issuer's free cash flow measured against its 2020 financial plan over one, two and three-year periods ending December 31, 2020, 2021 and 2022, respectively, and subject to the Reporting Person's continued employment with the Issuer and the conditions set forth in the Stock Unit Award Agreement. /s/ Brian G. Lloyd, Attorney-in-Fact 2020-03-10